143 results
DEFA14A
LRMR
Larimar Therapeutics Inc
19 Aug 20
Additional proxy soliciting materials
6:13am
the internet at:
www.meetingcenter.io/202792612
To access the virtual meeting, you must refer to the
“General Information” section of the proxy … view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to access and review all
S-1
EX-10.5
LRMR
Larimar Therapeutics Inc
18 Apr 14
IPO registration
12:00am
in the End User License Agreement (EULA) each new employee must accept in order to access TriNet’s on-line self-service portal: HR Passport.
You may indicate … Access
I accept the above terms of employment as stated:
/s/ Thomas E. Hughes
Thomas E. Hughes
Date
S-1
EX-10.4
LRMR
Larimar Therapeutics Inc
18 Apr 14
IPO registration
12:00am
No Recording
Appurtenant Rights
Tenant’s Access
Exclusions
RIGHTS RESERVED TO LANDLORD
Additions and Alterations
Additions to the Property
Name and Address … of Building
Landlord’s Access
Pipes, Ducts and Conduits
Minimize Interference
CONDITION OF PREMISES; CONSTRUCTION
Condition of Premises
Landlord’s Work
8-K
EX-10.1
uz65kla 0bsf0apc
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-99.2
84xx1ac 3i5lh
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
EX-99.1
quockxxa4mxd
25 Jul 23
Top-line safety, pharmacokinetic, and pharmacodynamic (frataxin level) data from Phase 2 trial’s 50 mg cohort expected in 1H 2024
7:02am
8-K
EX-99.1
81c5a8m d3d
16 Oct 15
Zafgen Announces Partial Clinical Hold Affecting Beloranib Trials
12:00am
8-K
EX-99.1
3wns1e
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm
8-K
EX-10.2
nurv9fglqykk
29 Sep 20
Departure of Directors or Certain Officers
7:06am